Jackson Lahmeyer has dropped out of the House race in Oklahoma's 1st Congressional District — one day after advancing to a runoff in the Republican primary — amid a text-messaging scandal. "After ...

There’s a lot to love about Jennifer Gross’s new Phoenix home. The stucco four-bedroom with a clay-tiled roof has a three-car garage, overlooks a park and comes with a brick-bordered pool and a hot ...

Blake has over a decade of experience writing for the web, with a focus on mobile phones, where he covered the smartphone boom of the 2010s and the broader tech scene. When he's not in front of a ...

Immediate draft grades provide a foundation for future evaluations. Waiting three years to assess draft classes without accounting for how the decision was viewed at the time usually leads to ...

Middle-Earth came to Las Vegas as part of Warner Bros.’ CinemaCon presentation Tuesday. The studio revealed several cast members for the upcoming “The Lord of the Rings: The Hunt for Gollum,” directed ...

If vanilla AI image generators leave you feeling underwhelmed, it's time to play with the spicy stuff. I put the most popular NSFW options to the test so you can find the one that really hits the mark ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...